Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis
Kyomin Choi(Konkuk University), Jeeyoung Oh(Université Paris-Sud), Ha Young Shin(Yonsei University), Young Cheol Choi(Yonsei University), Nam‐Hee Kim(Korea National Institute of Health), Eun-Seok Jeon(Samsung Medical Center), Ga Yeon Lee, Ju‐Hong Min(Samsung Medical Center), Jin-Myoung Seok(Soonchunhyang University), Il‐Nam Sunwoo, Jung‐Joon Sung(Seoul National University), Byoung-Joon Kim(Samsung Medical Center), Dae‐Seong Kim(Pusan National University Yangsan Hospital)
Cited by 14
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82